Tristel PLC
LSE:TSTL

Watchlist Manager
Tristel PLC Logo
Tristel PLC
LSE:TSTL
Watchlist
Price: 425 GBX -1.16% Market Closed
Market Cap: 202.7m GBX
Have any thoughts about
Tristel PLC?
Write Note

Tristel PLC
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tristel PLC
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Tristel PLC
LSE:TSTL
Cash from Operating Activities
ÂŁ10.2m
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
14%
Abingdon Health PLC
LSE:ABDX
Cash from Operating Activities
ÂŁ914k
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ConvaTec Group PLC
LSE:CTEC
Cash from Operating Activities
$367.4m
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Inspecs Group PLC
LSE:SPEC
Cash from Operating Activities
ÂŁ12.7m
CAGR 3-Years
N/A
CAGR 5-Years
23%
CAGR 10-Years
N/A
Advanced Medical Solutions Group PLC
LSE:AMS
Cash from Operating Activities
ÂŁ15.2m
CAGR 3-Years
-17%
CAGR 5-Years
-5%
CAGR 10-Years
0%
Rua Life Sciences PLC
LSE:RUA
Cash from Operating Activities
-ÂŁ1.3m
CAGR 3-Years
2%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
No Stocks Found

Tristel PLC
Glance View

Market Cap
201.4m GBX
Industry
Health Care

Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. The company is headquartered in Snailwell, Cambridgeshire and currently employs 189 full-time employees. The company went IPO on 2005-06-01. The Company’s technology is a chlorine dioxide formulation used by hospitals for the high-level disinfection of medical devices and the sporicidal disinfection of environmental surfaces. The Company’s segments include Hospital medical device decontamination and Hospital environmental surface disinfection. The firm manufactures and sells medical device decontamination products that are used primarily for infection control in hospitals. The firm also manufactures and sells hospital environmental surface disinfection products. The Tristel brand offers airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, phlebotomy, surfaces, ultrasound, urology, and women's health. The Crystel brand offers pharmaceutical, cosmetic and toiletry (PCT), cleanroom disinfectants and laboratory disinfectants. The company markets its products under the Tristel, Anistel, and Crystel brands.

TSTL Intrinsic Value
423.7 GBX
Fairly Valued
Intrinsic Value
Price

See Also

What is Tristel PLC's Cash from Operating Activities?
Cash from Operating Activities
10.2m GBP

Based on the financial report for Dec 31, 2023, Tristel PLC's Cash from Operating Activities amounts to 10.2m GBP.

What is Tristel PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
14%

Over the last year, the Cash from Operating Activities growth was 69%. The average annual Cash from Operating Activities growth rates for Tristel PLC have been 10% over the past three years , 12% over the past five years , and 14% over the past ten years .

Back to Top